145 related articles for article (PubMed ID: 35397199)
1. Short-Term Impact of the Frequency of COPD Exacerbations on Quality of Life.
Camac ER; Stumpf NA; Voelker HK; Criner GJ
Chronic Obstr Pulm Dis; 2022 Jul; 9(3):298-308. PubMed ID: 35397199
[TBL] [Abstract][Full Text] [Related]
2. Impact of COPD exacerbations leading to hospitalization on general and disease-specific quality of life.
Camac ER; Voelker H; Criner GJ;
Respir Med; 2021 Sep; 186():106526. PubMed ID: 34229290
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Normansell R; Maisey S; Poole P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009764. PubMed ID: 30376188
[TBL] [Abstract][Full Text] [Related]
4. Impact of COPD Exacerbation Frequency on Costs for a Managed Care Population.
Dalal AA; Patel J; D'Souza A; Farrelly E; Nagar S; Shah M
J Manag Care Spec Pharm; 2015 Jul; 21(7):575-83. PubMed ID: 26108382
[TBL] [Abstract][Full Text] [Related]
5. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
6. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A
NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794
[TBL] [Abstract][Full Text] [Related]
7. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
[TBL] [Abstract][Full Text] [Related]
8. The relationship between oral health and COPD exacerbations.
Baldomero AK; Siddiqui M; Lo CY; Petersen A; Pragman AA; Connett JE; Kunisaki KM; Wendt CH
Int J Chron Obstruct Pulmon Dis; 2019; 14():881-892. PubMed ID: 31114185
[No Abstract] [Full Text] [Related]
9. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.
Seemungal TA; Donaldson GC; Paul EA; Bestall JC; Jeffries DJ; Wedzicha JA
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1418-22. PubMed ID: 9603117
[TBL] [Abstract][Full Text] [Related]
10. Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry.
Fortis S; Wan ES; Kunisaki K; Eyck PT; Ballas ZK; Bowler RP; Crapo JD; Hokanson JE; Wendt C; Silverman EK; Comellas AP
Respir Med X; 2021 Nov; 3():. PubMed ID: 35911870
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
12. "Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.
Tomioka R; Kawayama T; Suetomo M; Kinoshita T; Tokunaga Y; Imaoka H; Matsunaga K; Okamoto M; Hoshino T
Int J Chron Obstruct Pulmon Dis; 2016; 11():207-16. PubMed ID: 26893552
[TBL] [Abstract][Full Text] [Related]
13. Clinical predictors of exacerbation frequency in chronic obstructive pulmonary disease.
Brusse-Keizer M; van der Palen J; van der Valk P; Hendrix R; Kerstjens H
Clin Respir J; 2011 Oct; 5(4):227-34. PubMed ID: 21106031
[TBL] [Abstract][Full Text] [Related]
14. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
Ni H; Htet A; Moe S
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
[TBL] [Abstract][Full Text] [Related]
15. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
Kew KM; Mavergames C; Walters JA
Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
[TBL] [Abstract][Full Text] [Related]
16. The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.
Kim V; Zhao H; Regan E; Han MK; Make BJ; Crapo JD; Jones PW; Curtis JL; Silverman EK; Criner GJ;
Chest; 2019 Oct; 156(4):685-695. PubMed ID: 31047955
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing decline in quality of life in smokers without airflow obstruction: The COPDGene study.
Parekh TM; Bhatia S; Cherrington A; Kim YI; Lambert A; Iyer A; Regan EA; DeMeo DL; Han M; Dransfield MT
Respir Med; 2020 Jan; 161():105820. PubMed ID: 31759270
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Functional Lung Parameters Associated With Frequent Exacerbator Phenotype in Subjects With Severe COPD.
Capozzolo A; Carratù P; Dragonieri S; Falcone VA; Quaranta VN; Liotino V; D'Alba G; Castellana G; Resta O
Respir Care; 2017 May; 62(5):572-578. PubMed ID: 28270543
[TBL] [Abstract][Full Text] [Related]
19. Relationship between depression and exacerbations in COPD.
Quint JK; Baghai-Ravary R; Donaldson GC; Wedzicha JA
Eur Respir J; 2008 Jul; 32(1):53-60. PubMed ID: 18321938
[TBL] [Abstract][Full Text] [Related]
20. Identification of proteomic signatures associated with COPD frequent exacerbators.
Sun P; Ye R; Wang C; Bai S; Zhao L
Life Sci; 2019 Aug; 230():1-9. PubMed ID: 31121174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
